M/Z: 905.544

Hit 2 annotations: [(2R)-3-[[(2R,3S,4S,5R)-5-(4-Amino-2-oxopyrimidin-1-yl)-4-cyano-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate_[M+Na]+; PGP(18:0/22:5(4Z,7Z,10Z,13Z,16Z))_[M+H]+

在BioDeep NovoCell知识数据库中，参考离子总共被划分为4个级别。

Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
Unreliable: 这个参考离子具有较高的排名价值，但缺乏可重复性。
Unavailable: 由于排名价值低且缺乏可重复性，这个参考离子不应用于注释。

Found 0 Reference Ions Near m/z 905.544

NovoCell ID	m/z	Mass Window	Metabolite	Ranking	Anatomy Context

Found 2 Sample Hits

Metabolite	Species	Sample
[(2R)-3-[[(2R,3S,4S,5R)-5-(4-Amino-2-oxopyrimidin-1-yl)-4-cyano-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate Formula: C45H79N4O11P (882.5483) Adducts: [M+Na]+ (Ppm: 5.1)	Homo sapiens (esophagus)	LNTO22_1_9 Resolution: 75μm, 89x74 Description
PGP(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) Formula: C46H82O13P2 (904.523) Adducts: [M+H]+ (Ppm: 15.1)	Homo sapiens (colorectal adenocarcinoma)	80TopL, 50TopR, 70BottomL, 60BottomR-profile Resolution: 17μm, 137x136 Description The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

Metabolite

Species

Sample

[(2R)-3-[[(2R,3S,4S,5R)-5-(4-Amino-2-oxopyrimidin-1-yl)-4-cyano-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate

Formula: C45H79N4O11P (882.5483)
Adducts: [M+Na]+ (Ppm: 5.1)

Homo sapiens (esophagus)

LNTO22_1_9

Resolution: 75μm, 89x74

Description

PGP(18:0/22:5(4Z,7Z,10Z,13Z,16Z))

Formula: C46H82O13P2 (904.523)
Adducts: [M+H]+ (Ppm: 15.1)

Homo sapiens (colorectal adenocarcinoma)

80TopL, 50TopR, 70BottomL, 60BottomR-profile

Resolution: 17μm, 137x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).